This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Dynegy: Pump Up The Volume

Stocks in this article: DYN BAK KERX

HOUSTON ( TheStreet) -- Dynegy (DYN) finished Thursday's session with gains on heavy volume on reports of a possible acquisition by NRG Energy (NRG).

Dynegy saw 44.4 million shares change hands Thursday, more than three times its three-month daily average, after reported market chatter about a NRG-for-Dynegy deal. Volume was greatest during the first half hour of trading, when Dynegy's stock hit an intraday high of $2.42. Shares pared gains but finished higher by 3 cents, or 1.3%, at $2.27. also noted that Dynegy Oct. 2009 calls were seeing greater interest than puts on the rumor.

Dynegy has a 840.2 million-share float with a small short interest float of 2.6% as of Aug. 26, according to Yahoo! Finance. NRG, on the other hand, has a float of 264 million and a short interest float of 6.5%. NRG has a market cap of $7.2 billion, compared to Dynegy's $1.9 billion market cap.

Investor posts on Internet message boards Thursday noted that short interest in Dynegy is considerably smaller than it was a year ago. Others argued that any takeover of Dynegy would see shares fetch a price between $4 and $5. Dynegy shares have a 52-week high of $4.30.

China BAK Rides A123's Coatails

China BAK Battery (CBAK) was trading sharply lower on above-average volume following the initial public offering of rival battery maker A123 Systems (AONE).

A123 shares jumped 53.8% to $20.76 in its debut. The maker of rechargeable lithium-ion batteries raised $380 million by offering 28.2 million shares. China BAK shares had surged into A123's IPO, rising nearly 30% Wednesday on heavy volume.

However, China BAK shares were lately down 42 cents, or 10.6%, to $3.56. More than 1.7 million changed hands, compared to the stock's 50-day average daily volume of 231,000, according to the Nasdaq's Web site. China BAK has a 37.7 million-share float with a small short interest float of 2.9% as of Aug. 11, according to Yahoo! Finance.

Investor posts on Internet message boards called Wednesday's rally in China BAK shares a "fluke." Others noted that insiders own more than 30% of the company. One commenter noted that A123's surge Thursday gave it a market cap well above China BAK's market share, which stands at $206 million, and argued that China BAK's should be greater.

Keryx Biopharmaceuticals Trades Down on Heavy Volume

Keryx Biopharmaceuticals (KERX) was trading lower Thursday on above-average volume one day after the company announced results of a successful trial of its kidney disease drug.

On Wednesday, Keryx said trial results indicated that long-term use of its Zerenex kidney disease drug for hyperphosphatemia, or elevated phosphate levels in the blood, can keep patients within the normal serum phosphorous range for extended periods of time and that the drug appears to be well-tolerated.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs